Anesthesia & Analgesia · 1993 · 60 citations · 0 references
MedicinePharmacologyToxicologyBiochemical PharmacologyDrug MetabolismHepatic PharmacokineticsAnesthetic Drug PharmacologyCytochrome P450 EnzymesCytochrome P450-mediated MetabolismDrug-metabolizing EnzymesHepatic Drug MetabolismCytochrome P450 Enzyme ActivityCytochrome P450 Enzyme InhibitionCytochrome P450 InhibitionCytochrome P450 IsoenzymesFluorination ProcessesMetabolic Enzyme InhibitionMicrosomal Drug MetabolismRat Liver Microsomes
The effects of propofol on cytochrome P450 activity in rat hepatic microsomes were evaluated to determine the potential influence of this anesthetic on the metabolism of coadministered agents. In microsomes from untreated and isoniazid-treated rats, propofol was a weak inhibitor of enflurane metabolism, inhibiting activity only at 0.35 mM propofol. In contrast, toluene, a related compound, effectively impaired enflurane defluorination in microsomes from untreated, and isoniazid- and phenobarbital-treated rats at concentrations as low as 0.025 mM. Propofol, in contrast to toluene, was an effective inhibitor of benzphetamine demethylation where it inhibited this activity at propofol concentrations as low as 0.025 mM in microsomes from phenobarbital-treated rats. In microsomes from phenobarbital-treated rats, propofol potently inhibited the metabolism of aniline. Sixty-four percent inhibition was achieved at 0.03 mM propofol, whereas toluene had no effect at 1 mM. These data demonstrate that propofol does not effectively inhibit enflurane metabolism performed by the isoniazid-inducible cytochrome P450IIE1 but effectively impairs activities of the phenobarbital-inducible cytochrome P450 isozymes.